ArticleJournal of clinical medicine2022

Levosimendan Administration May Provide More Benefit for Survival in Patients with Non-Ischemic Cardiomyopathy Experiencing Acute Decompensated Heart Failure.

Wei-Chieh Lee et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.